CAPRELSA

Identification of Caprelsa

Please sign up for a free trial to see the description of this product.

Examples of the descriptions of OTHER drugs:

Lipitor 10 mg

Apo-Irbesartan 150 mg

Crestor 20 mg

Google image searchProduct monograph

Active ingredient

vandetanib, 300 MG

DIN: 02378590

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: SANOFI-AVENTIS CANADA INC

Date: 05-APR-2024

ATC:

L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
L01EX — Other protein kinase inhibitors (ATC, ATC/DDD)
L01EX04 — VANDETANIB (ATC/DDD)

Reference brand drug: Caprelsa

External Links for Caprelsa

Search on Google

Caprelsa side effects
Caprelsa dosage
vandetanib side effects
vandetanib dosage

Sanofi-Aventis Canada Inc

Go to Sanofi-Aventis website to see drug product details. Sometimes you can find caprelsa photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.